These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10230499

  • 1. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice.
    Kim HS, Park IS, Lim HK, Choi HS.
    Arch Pharm Res; 1999 Apr; 22(2):113-8. PubMed ID: 10230499
    [Abstract] [Full Text] [Related]

  • 2. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice.
    Kim HS, Park IS, Park WK.
    Life Sci; 1998 Apr; 63(26):2305-11. PubMed ID: 9877220
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice.
    Kim HS, Son YR, Kim SH.
    Life Sci; 1999 Apr; 64(26):2463-70. PubMed ID: 10403505
    [Abstract] [Full Text] [Related]

  • 4. N-Methyl-D-aspartate receptor antagonists enhance the head-twitch response, a 5-hydroxytryptamine2 receptor-mediated behaviour, in reserpine-treated mice.
    Kim HS, Park IS, Lim HK, Choi HS, Oh S, Park WK, Jang CG, Kim SH, Chang MJ.
    J Pharm Pharmacol; 2000 Jun; 52(6):717-22. PubMed ID: 10875549
    [Abstract] [Full Text] [Related]

  • 5. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
    Kim HS, Rhee GS, Oh S, Park WK.
    Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice.
    Kim HS, Rhee GS, Jung JY, Lee JH, Jang CG, Park WK.
    Life Sci; 1996 Apr; 58(17):1397-402. PubMed ID: 8622565
    [Abstract] [Full Text] [Related]

  • 7. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML.
    J Neural Transm (Vienna); 1998 Apr; 105(4-5):365-96. PubMed ID: 9720968
    [Abstract] [Full Text] [Related]

  • 8. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
    Fukumoto K, Iijima M, Chaki S.
    Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K.
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [Abstract] [Full Text] [Related]

  • 11. 5-HT1 and 5-HT2 receptor activation reduces N-methyl-D-aspartate (NMDA)-stimulated LH secretion in prepubertal male and female rats.
    Pinilla L, Gonzalez LC, Tena-Sempere M, Aguilar E.
    Eur J Endocrinol; 2003 Jan; 148(1):121-7. PubMed ID: 12534365
    [Abstract] [Full Text] [Related]

  • 12. Role of the inhibitory adrenergic alpha 2 and serotonergic 5-HT1A components of cocaine's actions on the DOI-induced head-twitch response in 5-HT2-receptor supersensitive mice.
    Darmani NA.
    Pharmacol Biochem Behav; 1993 Jun; 45(2):269-74. PubMed ID: 8392199
    [Abstract] [Full Text] [Related]

  • 13. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH, Mendez-David I, Defaix C, Guiard BP, Tritschler L, David DJ, Gardier AM.
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [Abstract] [Full Text] [Related]

  • 14. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
    Darmani NA, Martin BR, Glennon RA.
    Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
    [Abstract] [Full Text] [Related]

  • 15. Activation of serotonergic 5-HT1A receptor reduces Ca(2+)- and glutamatergic receptor-evoked arachidonic acid and No/cGMP release in adult hippocampus.
    Strosznajder J, Chalimoniuk M, Samochocki M.
    Neurochem Int; 1996 Apr; 28(4):439-44. PubMed ID: 8740452
    [Abstract] [Full Text] [Related]

  • 16. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists.
    Ginski MJ, Witkin JM.
    Psychopharmacology (Berl); 1994 May; 114(4):573-82. PubMed ID: 7855218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.
    Darmani NA, Martin BR, Pandey U, Glennon RA.
    Pharmacol Biochem Behav; 1991 Feb; 38(2):353-7. PubMed ID: 1676173
    [Abstract] [Full Text] [Related]

  • 19. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M, Shimizu T, Nomoto M, Fukuda T.
    Pharmacol Biochem Behav; 1995 Feb; 51(2-3):291-6. PubMed ID: 7667342
    [Abstract] [Full Text] [Related]

  • 20. alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
    Matsumoto K, Mizowaki M, Thongpraditchote S, Murakami Y, Watanabe H.
    Pharmacol Biochem Behav; 1997 Mar; 56(3):417-22. PubMed ID: 9077577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.